Voorbeelden van het gebruik van Unacceptable toxicity in het Engels en hun vertalingen in het Nederlands
{-}
-
Medicine
-
Colloquial
-
Official
-
Ecclesiastic
-
Financial
-
Computer
-
Ecclesiastic
-
Official/political
-
Programming
Both study arms treatment was administered until disease progression or development of an unacceptable toxicity.
Treatment with Cotellic should continue until the patient no longer derives benefit or until the development of unacceptable toxicity see Table 1 below.
Treatment with vemurafenib should continue until disease progression or the development of unacceptable toxicity see tables 1
Patients(n 110) received 3.6 mg/kg of trastuzumab emtansine intravenously every 3 weeks until disease progression or unacceptable toxicity.
placebo in combination with BR until disease progression, or unacceptable toxicity.
Treatment with TORISEL should continue until the patient is no longer clinically benefiting from therapy or until unacceptable toxicity occurs.
Treatment should continue as long as clinical benefit is observed or until unacceptable toxicity occurs.
It is recommended that patients continue treatment with trametinib until patients no longer derive benefit or the development of unacceptable toxicity.
It is recommended that treatment be continued until disease progression or until unacceptable toxicity has occurred.
The recommended dose of KEYTRUDA is 2 mg/kg administered as an intravenous infusion over 30 minutes every three weeks until disease progression or unacceptable toxicity.
Treatment may be continued as long as there is no evidence of progressive disease or unacceptable toxicity.
8 of each 3 week cycle until disease progression or unacceptable toxicity.
Patients(n 391) were randomised 1:1 to receive either IMBRUVICA 420 mg daily until disease progression or unacceptable toxicity, or ofatumumab for up to 12 doses 300/2,000 mg.
deterioration in performance status) or unacceptable toxicity.
800 mg daily until disease progression or unacceptable toxicity.
Patients received treatment until disease progression or unacceptable toxicity.
Treatment may be continued until disease progression or until unacceptable toxicity occurs.
Patients were treated until disease progression or unacceptable toxicity occurred.
Patients continued therapy until disease progression or unacceptable toxicity see section 4.2.
It is recommended that treatment be continued until progression of the underlying disease or until unacceptable toxicity.